HIV-I Tat: immunosuppression via TGF-beta 1 induction

被引：49

作者：

Reinhold, D ^{[1
]}

Wrenger, S ^{[1
]}

Kahne, T ^{[1
]}

Ansorge, S ^{[1
]}

机构：

[1] Univ Magdeburg, Inst Expt Internal Med, D-39120 Magdeburg, Germany

来源：

IMMUNOLOGY TODAY | 1999年 / 20卷 / 08期

关键词：

D O I：

10.1016/S0167-5699(99)01497-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：384 / 384

页数：1

共 10 条

[1]

CUPP C, 1993, ONCOGENE, V8, P2231

[2] RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TAT PROTEIN SEQUENTIALLY UP-REGULATES IL-6 AND TFG-BETA-1 MESSENGER-RNA EXPRESSION AND PROTEIN-SYNTHESIS IN PERIPHERAL-BLOOD MONOCYTES [J].

GIBELLINI, D ;

ZAULI, G ;

RE, MC ;

MILANI, D ;

FURLINI, G ;

CARAMELLI, E ;

CAPITANI, S ;

LAPLACA, M .

BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (02) :261-267

[3] HUMAN-IMMUNODEFICIENCY-VIRUS-1 TAT BINDS TO DIPEPTIDYL AMINOPEPTIDASE-IV (CD26) - A POSSIBLE MECHANISM FOR TATS IMMUNOSUPPRESSIVE ACTIVITY [J].

GUTHEIL, WG ;

SUBRAMANYAM, M ;

FLENTKE, GR ;

SANFORD, DG ;

MUNOZ, E ;

HUBER, BT ;

BACHOVCHIN, WW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) :6594-6598

[4]

Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363

[5]

LOTZ M, 1990, FASEB J, V4, pA2014

[6] Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-beta 1 (TGF-beta 1) in stimulated mouse splenocytes and thymocytes [J].

Reinhold, D ;

Bank, U ;

Buhling, F ;

Tager, M ;

Born, I ;

Faust, J ;

Neubert, K ;

Ansorge, S .

IMMUNOLOGY LETTERS, 1997, 58 (01) :29-35

[7] Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta(1) in PWM-stimulated PBMC and T cells [J].

Reinhold, D ;

Bank, U ;

Buhling, F ;

Lendeckel, U ;

Faust, J ;

Neubert, K ;

Ansorge, S .

IMMUNOLOGY, 1997, 91 (03) :354-360

[8] HIV-I Tat: A polypeptide for all seasons [J].

Rubartelli, A ;

Poggi, A ;

Sitia, R ;

Zocchi, MR .

IMMUNOLOGY TODAY, 1998, 19 (12) :543-545

[9] Regulation of TNFα and TGFβ-1 gene transcription by HIV-1 Tat in CNS cells [J].

Sawaya, BE ;

Thatikunta, P ;

Denisova, L ;

Brady, J ;

Khalili, K ;

Amini, S .

JOURNAL OF NEUROIMMUNOLOGY, 1998, 87 (1-2) :33-42

[10] The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth [J].

Wrenger, S ;

Hoffmann, T ;

Faust, J ;

MrestaniKlaus, C ;

Brandt, W ;

Neubert, K ;

Kraft, M ;

Olek, S ;

Frank, R ;

Ansorge, S ;

Reinhold, D .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30283-30288

← 1 →